Herbst, Z.M., Urdaneta, L., Klein, T., Fuller, M. and Gelb, M.H., 2020. Evaluation of multiple methods for quantification of glycosaminoglycan biomarkers in newborn dried blood spots from patients with severe and attenuated mucopolysaccharidosis-I. International journal of neonatal screening, 6(3), p.69.
Herbst, Z.M., Urdaneta, L., Klein, T., Burton, B.K., Basheeruddin, K., Liao, H.C., Fuller, M. and Gelb, M.H., 2022. Evaluation of two methods for quantification of glycosaminoglycan biomarkers in newborn dried blood spots from patients with severe and attenuated mucopolysaccharidosis Type II. International Journal of Neonatal Screening, 8(1), p.9.
Herbst, Z.M., Kubaski, F., Pollard, L., Basheeruddin, K., Burton, B., Orsini, J., Henderson, M., Chakraborty, P. and Gelb, M.H., 2025. High precision newborn screening for mucopolysaccharidosis type I by enzymatic activity followed by endogenous, non-reducing end glycosaminoglycan analysis. Molecular genetics and metabolism, 144(2), p.108612.
Gholap, S.P., Herbst, Z., Paranji, R.K. and Gelb, M.H., 2025. Synthesis of the endogenous non-reducing end heparan sulfate disaccharide for newborn screening and diagnosis of Mucopolysaccharidosis type IIIA. Carbohydrate research, 555, p.109584.
